Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of July 05, 2020
DNA barcoding allows tracking of clonal dynamics after gene therapy
From the Adair and Kiem Groups, Clinical Research Division
Tip Sheet: HIV and COVID-19, antibody interactions, immune responses to colorectal cancer and how Fred Hutch is getting back to work
SEATTLE – June 2, 2020 – Below are summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.
$3.5M grant to develop safer treatment for inherited blood disorders
Scientists will study radioactive particles that can precisely deliver a potent punch
Dr. Hans-Peter Kiem elected vice president of American Society of Gene & Cell Therapy
After serving 1 year as vice president, Kiem will serve as president-elect and president of the society
Dr. Hans-Peter Kiem speaks about HIV and making gene therapy more accessible at TEDxSeattle
His talk is now available online
Science on the horizon
Fred Hutch experts make predictions for science trends, advances in 2020
Gimme shelter: CRISPR hides healthy cells from leukemia drug
In mouse study, gene-edited cells stay safe as immunotherapy attacks cancer
World AIDS Day: Stepping up the search for a cure
New funding from Gates Foundation and NIH give vote of confidence for an audacious goal
Scientists gather in Seattle to share strategies for an HIV cure
Workshop focuses on ways to lower cost, broaden reach of gene therapy
Conference on gene therapy for HIV cures will highlight progress and challenges ahead
Dr. Robert Siliciano, keynote speaker, discovered why AIDS drugs alone cannot cure HIV
Targeting a subset of stem cells shows lasting, therapeutically relevant gene editing in blood cells
A new Science Translational Medicine paper is first to report how editing a portion of stem cells with CRISPR/Cas9 is sufficient for long-term reactivation of therapeutic hemoglobin
London transplant doctors report a second person likely cured of HIV
12 years after Timothy Ray Brown was cured, we have another
Drs. Denise Galloway and Hans-Peter Kiem receive endowed chairs
Paul Stephanus Memorial Endowed Chair to Galloway; Stephanus Family Endowed Chair for Cell and Gene Therapy to Kiem
The prized fraction of Fanconi Anemia
from the Adair lab and the Kiem lab, Clinical Research Division
Dr. Geoffrey Hill 3rd recipient of José Carreras/E. Donnall Thomas Endowed Chair for Cancer Research
Endowments provide faculty with freedom and flexibility to pursue critical research endeavors
Taking the good out of viruses to cure immunodeficiencies by in vivo gene therapy
from the Kiem lab, Clinical Research Division
One step closer to the Berlin Patient and an HIV cure
Kiem Lab, Clinical Research Division and Vaccine and Infections Disease Division
Gene editing shows promise for sickle cell and related disorders
Preclinical results offer new hope in group of dangerous inborn diseases
Dr. Reema Jain developing methods to isolate, manipulate blood stem cells for T-cell therapy
Funding from Immunotherapy Integrated Research Center supports postdoc’s work
Gene editing holds promise for shrinking HIV ‘reservoir’
Study mimicking Timothy Ray Brown’s HIV-resistant mutation led to fewer latently infected cells — a key step toward driving the virus into remission without the need for antivirals